Ikuko Kato1, Anne Victoria Neale. 1. Karmanos Cancer Institute, Wayne State University School of Medicine, 110 E Warren Avenue, Detroit, Michigan, USA. katoi@karmanos.org
Abstract
BACKGROUND: The role of complementary and alternative medicine (CAM) in cancer treatment is controversial. The aim of the study was to assess whether CAM use was associated with a delay in the initiation of conventional cancer treatment for head and neck cancer. METHODS: CAM usage data were collected by mailed questionnaire for 149 incident head and neck cancer patients who were identified through the Metropolitan Detroit Cancer Surveillance System. Time from cancer diagnosis to the start of conventional cancer treatment was analyzed by the Kaplan-Meier method. RESULTS: Overall 79% of the subjects reported use of at least 1 of the CAM items asked in the questionnaire. The time to conventional cancer treatment did not differ by prior CAM use intended to treat cancer (p =.209). CONCLUSIONS: The results of the present registry-based study do not suggest that alternative therapy use in patients with head and neck cancer delays conventional cancer treatment.
BACKGROUND: The role of complementary and alternative medicine (CAM) in cancer treatment is controversial. The aim of the study was to assess whether CAM use was associated with a delay in the initiation of conventional cancer treatment for head and neck cancer. METHODS: CAM usage data were collected by mailed questionnaire for 149 incident head and neck cancerpatients who were identified through the Metropolitan Detroit Cancer Surveillance System. Time from cancer diagnosis to the start of conventional cancer treatment was analyzed by the Kaplan-Meier method. RESULTS: Overall 79% of the subjects reported use of at least 1 of the CAM items asked in the questionnaire. The time to conventional cancer treatment did not differ by prior CAM use intended to treat cancer (p =.209). CONCLUSIONS: The results of the present registry-based study do not suggest that alternative therapy use in patients with head and neck cancer delays conventional cancer treatment.
Authors: Heather Greenlee; Alfred I Neugut; Laura Falci; Grace Clarke Hillyer; Donna Buono; Jeanne S Mandelblatt; Janise M Roh; Isaac J Ergas; Marilyn L Kwan; Marion Lee; Wei Yann Tsai; Zaixing Shi; Lois Lamerato; Lawrence H Kushi; Dawn L Hershman Journal: JAMA Oncol Date: 2016-09-01 Impact factor: 31.777
Authors: Paul F Pinsky; Kelly Yu; Barnett S Kramer; Amanda Black; Saundra S Buys; Edward Partridge; John Gohagan; Christine D Berg; Philip C Prorok Journal: Gynecol Oncol Date: 2016-09-09 Impact factor: 5.482
Authors: Wenpeng Zhang; Tao Zhang; Runsen Jin; Hongchao Zhao; Jin Hu; Bo Feng; Lu Zang; Minhua Zheng; Mingliang Wang Journal: J Exp Clin Cancer Res Date: 2014-12-31
Authors: Rosanne C Schoonbeek; Suzanne Festen; Roza Rashid; Boukje A C van Dijk; György B Halmos; Lilly-Ann van der Velden Journal: Otolaryngol Head Neck Surg Date: 2022-01-19 Impact factor: 5.591